媒体报导

www.in-pharmatechnologist.com/Drug-Delivery/Oramed-inks-China-licensing-deal-for-oral-insulin-candidate

www.timesofisrael.com/oramed-inks-huge-50m-deal-with-chinese-pharma-firm/?utm_source=dlvr.it&utm_medium=twitter

Josh Hexter, Oramed's COO, met with SNNLive at the Aegis Conference in August about Oramed and it's progress http://stocknewsnow.com/commentary/ANEWSID08112015100001/$ORMP-SNNLive-Video-Interview-with-Oramed-Pharmaceuticals

Josh Hexter, Oramed's COO, spoke with BioPharma Dive about Oramed's product and progress. “Our oral insulin is not a substitute for insulin injections, but rather a new, earlier treatment option.” http://www.biopharmadive.com/news/a-21st-century-diabetes-option-will-oramed-be-first-to-market-with-oral-in/402100/

http://seekingalpha.com/instablog/1240561-ray-dirks/4161215-orameds-quick-road-to-market-as-global-leader-of-oral-insulin-capsule

By: Dan Stanton http://www.in-pharmatechnologist.com/Drug-Delivery/Oramed-Desire-for-alternative-insulin-delivery-shown-with-Afrezza

Listen in to find out more about these made-in-Israel technologies aimed at improving quality of life for people with diabetes (audio): http://www.israel21c.org/headlines/tech-firms-target-diabetes-audio/?utm_content=bufferff52d&utm_medium=social&utm_source=facebook.com&utm_campaign=buffer

http://www.reuters.com/video/2014/03/30/reuters-tv-clinical-trials-hold-promise-for-worlds?videoId=300847050&videoChannel=118065

http://www.bloomberg.com/news/2014-01-30/oral-diabetes-medicine-shows-promise-in-study-of-oramed-pill.html

http://www.reuters.com/article/2014/01/30/us-oramed-trial-idUSBREA0T0LR20140130